Mineralys Therapeutics Inc (MLYS)

Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	442.66%246.04	45.34	38.28	41.13	46.75
Research and Development	808.59%221.38	24.37	24.40	31.45	38.28
Operating Income/Loss	442.66%-246.04	-45.34	-38.28	-41.13	-46.75
Nonoperating Income/Loss	17.20%4.97	6.00	6.05	4.20	3.47
	512.80%-241.07	-39.34	-32.23	-36.93	-43.27
Attributable To Parent	512.80%-241.07	-39.34	-32.23	-36.93	-43.27
Basic Average Shares	2.28%84.73	82.83	-	70.59	65.45
Diluted Average Shares	2.28%84.73	82.83	-	70.59	65.45
Basic Earnings Per Share	506.38%-2.85	-0.47	-	-0.52	-0.66
Diluted Earnings Per Share	506.38%-2.85	-0.47	-	-0.52	-0.66